Hi Rong,
Good question.
Here in the Netherlands I would argue that one chooses the generic
name first since (at least GP's) doctors have to prescribe drugs by
their generic name. The idea behind this is that if drugs are 'off
patent', the often more expensive 'brand' drugs aren't prescribed
automatically.
It might also be easier from a practical perspective that the generic
name is prevailing: There is only one generic drug name per drug but
their can be many brand/commercial names for the same drug, especially
if it's off patent. Especially with 'older' drug most doctors know the
generic name, but don't know all the brand/commercial names. See for
instances how many brand drugs contain acetylsalicylic acid.
Cheers,
Stef
Op 21 okt 2009, om 15:43 heeft Rong Chen het volgende geschreven:
> Dear all,
>
> In the Swedish archetype project, we need to record medication
> information with the medication archetype from the openEHR knowledge
> repository. We have difficulties to decide on which archetype node to
> use in the medication archetype
> ("openEHR-EHR-ITEM_TREE.medication.v1") for the name of the medication
> and the ATC code. There are at least two possibilities here, both
> "Name of the medication" and "Generic name of the medication" seems to
> be possible. Should we use the "Name of medication" to keep the
> medication name and use "Generic name" for ATC code or the other way
> around?
>
> Cheers,
> Rong
> _______________________________________________
> openEHR-clinical mailing list
> openEHR-clinical at openehr.org
> http://lists.chime.ucl.ac.uk/mailman/listinfo/openehr-clinical
-------------- next part --------------
An HTML attachment was scrubbed...
URL:
<http://lists.openehr.org/mailman/private/openehr-clinical_lists.openehr.org/attachments/20091021/28760f8d/attachment.html>
